186 related articles for article (PubMed ID: 29357040)
1. Hepatic cavernous hemangiomas: long-term (> 5 years) follow-up changes on contrast-enhanced dynamic computed tomography or magnetic resonance imaging and determinant factors of the size change.
Choi J; Yu JS; Cho ES; Kim JH; Chung JJ
Radiol Med; 2018 May; 123(5):323-330. PubMed ID: 29357040
[TBL] [Abstract][Full Text] [Related]
2. Sclerotic changes of cavernous hemangioma in the cirrhotic liver: long-term follow-up using dynamic contrast-enhanced computed tomography.
Shin N; Choi JA; Choi JM; Cho ES; Kim JH; Chung JJ; Yu JS
Radiol Med; 2020 Dec; 125(12):1225-1232. PubMed ID: 32415477
[TBL] [Abstract][Full Text] [Related]
3. Hepatic cavernous hemangiomas: lack of enlargement over time.
Mungovan JA; Cronan JJ; Vacarro J
Radiology; 1994 Apr; 191(1):111-3. PubMed ID: 8134554
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of Hepatic Sclerosed Hemangiomas From Cavernous Hemangiomas Based on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging Features.
Hwang JA; Kang TW; Cha DI; Kim SH; Ha SY; Kim SW
J Comput Assist Tomogr; 2019; 43(5):762-769. PubMed ID: 31356526
[TBL] [Abstract][Full Text] [Related]
5. MR diagnosis of hepatic metastases from neuroendocrine tumors versus hemangiomas: relative merits of dynamic gadolinium chelate-enhanced gradient-recalled echo and unenhanced spin-echo images.
Soyer P; Gueye C; Somveille E; Laissy JP; Scherrer A
AJR Am J Roentgenol; 1995 Dec; 165(6):1407-13. PubMed ID: 7484575
[TBL] [Abstract][Full Text] [Related]
6. Distinction between cavernous hemangiomas of the liver and hepatic metastases on CT: value of contrast enhancement patterns.
Leslie DF; Johnson CD; Johnson CM; Ilstrup DM; Harmsen WS
AJR Am J Roentgenol; 1995 Mar; 164(3):625-9. PubMed ID: 7863883
[TBL] [Abstract][Full Text] [Related]
7. Hepatic cavernous hemangioma: sonographic patterns and speed of contrast enhancement on multiphase dynamic MR imaging.
Yu JS; Kim MJ; Kim KW; Chang JC; Jo BJ; Kim TH; Lee JT; Yoo HS
AJR Am J Roentgenol; 1998 Oct; 171(4):1021-5. PubMed ID: 9762989
[TBL] [Abstract][Full Text] [Related]
8. Ferucarbotran-enhanced T2-weighted magnetic resonance imaging: differentiation of hepatic cavernous hemangiomas from malignant solid lesions.
Cho ES; Yu JS; Ahn JH; Park MS; Kim JH; Chung JJ; Kim KW
Abdom Imaging; 2009 Jul; 34(4):494-501. PubMed ID: 18546032
[TBL] [Abstract][Full Text] [Related]
9. Assessing normal growth of hepatic hemangiomas during long-term follow-up.
Hasan HY; Hinshaw JL; Borman EJ; Gegios A; Leverson G; Winslow ER
JAMA Surg; 2014 Dec; 149(12):1266-71. PubMed ID: 25321079
[TBL] [Abstract][Full Text] [Related]
10. Transcatheter arterial embolization in the treatment of symptomatic cavernous hemangiomas of the liver: a prospective study.
Srivastava DN; Gandhi D; Seith A; Pande GK; Sahni P
Abdom Imaging; 2001; 26(5):510-4. PubMed ID: 11503090
[TBL] [Abstract][Full Text] [Related]
11. Comparative diagnostic value of contrast-enhanced ultrasonography, computed tomography, and magnetic resonance imaging in diagnosis of hepatic hemangiomas.
Zviniene K; Zaboriene I; Basevicius A; Jurkiene N; Barauskas G; Pundzius J
Medicina (Kaunas); 2010; 46(5):329-35. PubMed ID: 20679748
[TBL] [Abstract][Full Text] [Related]
12. Hepatic cavernous hemangioma in cirrhotic liver: imaging findings.
Yu JS; Kim KW; Park MS; Yoon SW
Korean J Radiol; 2000; 1(4):185-90. PubMed ID: 11752953
[TBL] [Abstract][Full Text] [Related]
13. Capsular retraction in hepatic giant hemangioma: CT and MR features.
Yang DM; Yoon MH; Kim HS; Kim HS; Chung JW
Abdom Imaging; 2001; 26(1):36-8. PubMed ID: 11116357
[TBL] [Abstract][Full Text] [Related]
14. Temporal peritumoral enhancement of hepatic cavernous hemangioma: findings at multiphase dynamic magnetic resonance imaging.
Li CS; Chen RC; Chen WT; Lii JM; Tu HY
J Comput Assist Tomogr; 2003; 27(6):854-9. PubMed ID: 14600449
[TBL] [Abstract][Full Text] [Related]
15. Ultra-low field MR imaging of hepatic hemangiomas (at 0.02 and 0.04 T).
Ekelund L; Björnebrink J; Athlin L
Eur J Radiol; 1992; 14(1):41-5. PubMed ID: 1563403
[TBL] [Abstract][Full Text] [Related]
16. Hepatic cavernous hemangioma: appearance on T2-weighted fast spin-echo MR imaging with and without fat suppression.
Soyer P; Dufresne AC; Somveille E; Scherrer A
AJR Am J Roentgenol; 1997 Feb; 168(2):461-5. PubMed ID: 9016227
[TBL] [Abstract][Full Text] [Related]
17. Cavernous hemangiomas in patients with chronic liver disease: MR imaging findings.
Mastropasqua M; Kanematsu M; Leonardou P; Braga L; Woosley JT; Semelka RC
Magn Reson Imaging; 2004 Jan; 22(1):15-8. PubMed ID: 14972389
[TBL] [Abstract][Full Text] [Related]
18. Computed tomography and magnetic resonance imaging findings of nasal cavity hemangiomas according to histological type.
Kim JH; Park SW; Kim SC; Lim MK; Jang TY; Kim YJ; Kang YH; Lee HY
Korean J Radiol; 2015; 16(3):566-74. PubMed ID: 25995686
[TBL] [Abstract][Full Text] [Related]
19. Differential diagnosis of hepatic neoplasms: spin echo versus gadolinium-diethylenetriaminepentaacetate-enhanced gradient echo imaging.
Abbas YA; Kressel HY; Wehrli FW; Gefter WB; Dinsmore BJ; Chan TW; Oleaga L; Milestone BN; Outwater EK
Magn Reson Q; 1991 Oct; 7(4):275-92. PubMed ID: 1790113
[TBL] [Abstract][Full Text] [Related]
20. Natural course of cavernous hepatic hemangioma.
Okano H; Shiraki K; Inoue H; Ito T; Yamanaka T; Deguchi M; Sugimoto K; Sakai T; Ohmori S; Murata K; Takase K; Nakano T
Oncol Rep; 2001; 8(2):411-4. PubMed ID: 11182065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
